Nasal administration of quercetin liposomes improves memory impairment and neurodegeneration in animal model of Alzheimer's disease

American Journal of Agricultural and Biological Science

Volumn 5, Issue 3, 2010, Pages 286-293

  Tong Un, Terdthai ^a   Muchimapura, Supaporn ^a   Wattanathorn, Jintanaporn ^a   Phachonpai, Wathita ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Alzheimer's disease; Morris water maze test; Nasal administration; Quercetin liposome's; Spatial memory

Indexed keywords

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 79959853124     PISSN: 15574989     EISSN: 15574997     Source Type: Journal    
DOI: 10.3844/ajabssp.2010.286.293     Document Type: Article

References (37)

1. Auld, D.S., T.J. Kornecook, S. Bastianetto and R. Quirion, 2002. Alzheimer's disease and the basal forebrain cholinergic system: Relations to β- amyloid peptides cognition and treatment strategies. Prog. Neurobiol., 68: 209-245. PMID: 124504886
2. Bhattaram, V.A., U. Graefe, C. Kohlert, M. Veit and H. Derendorf, 2002. Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedical, 9: 1-33. DOI: 10.1078/1433-187X-002106
3. Boer, V.C.J., A.A. Dihal, H. Van Der Woude, I.C.W. Arts and S. Wolffram et al., 2005. Tissue distribution of quercetin in rats and pigs. J. Nutr., 135:1617-1618. PMID: 159878556
4. Bondy, S.C., 1995. The relation of oxidative stress and hyperexcitation to neurological disease, Proc. Soc. Exp. Biol. Med., 208: 337-345 PMID: 77008836
5. Boots, A.W., G.R. Haenen and A. Bast, 2008. Health effects of quercetin: From antioxidant to nutraceutical. Eur. J. Pharmacol., 585: 325-337. DOI: 10.1016/j.ejphar.2008.03.0086
6. Cantuti, C.I., B. Shukitt-Hale and J.A. Joseph, 2000. Neurobehavioural aspects of antioxidants in aging. J. Neurosci., 18: 367-381. DOI: 10.1016/S0736-5748(00)00008-3
7. Cho, J.Y., I.S. Kim, Y.H. Jang, A.R. Kim and S.R. Lee, 2006. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neurosci. Lett., 404: 330-335. PMID: 168066986 DOI: 10.1016/j.neulet.2006.06.0106
8. Formica, J.V. and W. Regelson, 1995. Review of the biology of quercetin and related bioflavonoids. Food. Chem. Toxicol., 33: 1061-1080. PMID: 88470036
9. Graf, B.A., C. Ameho, G.G. Dolnikowski, P.E. Milbury and C.Y. Chen et al., 2006. Rat gastrointestinal tissues metabolized quercetin. J. Nutr., 136: 39-44. PMID: 163650566
10. Guo, J., Q. Ping, G. Jiang, L. Huang and Y. Tong, 2003. Chitosan-coated liposomes: Characterization and interaction with leuprolide. Int. J. Pharm., 260: 167-173. DOI: 10.1016/S0378- 5173(03)00254-06
11. Hagg, T., 2005. Molecular regulation of adult CNS neurogenesis: An integrated view. Trends Neurosci., 28: 589-595. DOI: 10.1016/j.tins.2005.08.0096
12. Hanin, I., 1996. The AF64A model of cholinergic hypofunction: An update. Life Sci., 58: 1955-1964. DOI: 10.1016/0024-3205(96)00185-36
13. Illum, L., 2000 Transport of drugs from the nasal cavity to the central nervous system. Eur. J. Pharm. Sci., 11: 1-18. PMID: 109137486
14. Jamal, T., S. Jean-Michel, R.R. Anthony and K. Michel, 2000. Brain drug delivery technologies: Novel approaches for transporting therapeutics. Pharm. Sci. Technol., 3: 155-162. PMID: 107856576
15. Katzman, R., 1986. Alzheimer's disease. N. Engl. J. Med., 314: 964-973. PMID: 28704336
16. Lamson, D.W. and M.S. Brignall, 2000. Antioxidants and cancer. Part III. quercetin. Altern. Med., 5: 196-208. PMID: 108691016
17. Liang, M.T., N.M. Davies and I. Toth, 2005. Encapsulation of lipopeptides within liposomes: Effect of number of lipid chains, chain length and method of liposome preparation. Int. J. Pharm., 301: 247-254. PMID: 160547876 DOI: 10.1016/j.ijpharm.2005.06.0106
18. Manach, C., C. Morand, V. Crespy, C. Demignee and O. Texier et al., 1998. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett., 426: 331-336. PMID: 96002616
19. Manach, C., A. Scalbert, C. Morand, C. Remesy and L. Jimenez, 2004. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr., 79: 727-747. PMID: 151137106
20. Mandelkow, E., M.V. Bergen, J. Biernet and E.V. Mandelkow, 2007. Structural principles of tau and the paired helical filaments of Alzheimer's disease. Brain. Pathol., 17: 83-90. PMID: 174930426
21. Mattson, M.P., 2004. Pathways towards and away from Alzheimer's disease. Nature, 430: 631-639. DOI: 10.1038/nature026216
22. McDonald, M.D. and J.B. Overmier, 1998. Present imperfect: A critical review of animal models of the mnemonic impairments in Alzheimer's disease. Neurosci. Biobehav. Rev., 22: 99-120. DOI: 10.1016/S0149-7634(97)00024-96
23. Metodiewa, D., A.K. Jaiswal, N. Cenas, E. Dickancaite and J. Segura-Aguilar, 1999. Quercetin may act as a cytotoxic prooxidant after its methanolic activation to semiquinone and quinoidal product. Free. Radic. Biol. Med., 26: 107-116. PMID: 98906466
24. Middleton, E., C. Kandaswami and T.C. Theoharides, 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharm. Rev., 52: 673-751. PMID: 111215136
25. Mori, E., H. Hirono, H. Yamashita, T. Imamura and Y. Ikejiri et al., 1997. Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. Am. J. Psychiat., 154: 18-24. PMID: 89889536
26. Naumenko, V.S. and A.V. Kulikov, 2006. Quantitative assay of 5-HT (1A) serotonin receptor gene expression in the brain. Molekuliarnaia Biol., 40: 37-44. PMID: 165236906
27. Ohnishi, E. and H. Bannai, 1993. Quercetin potentiates TNF-induced antiviral activity. Antiv. Res., 22: 327-331. PMID: 82798196
28. Olanow, C.W., 1993. Aradical hypothesis for neurodegeneration. Trends Pharma. Sci., 16: 439. PMID: 75076136
29. Reiter, M., K. Rupp, P. Baumeister, S. Zieger and U. Harreus, 2009. Antioxidant effects of quercetin and coenzyme Q106 in mini organ cultures of human nasal mucosa cells. Anticancer Res., 29: 33-39. PMID: 193311316
30. Sharma, A. and U.S. Sharma, 1997. Liposomes in drug delivery: Process and limitations. Int. J. Pharm., 154: 123-140.
31. Sinha, J., N. Das and M.K. Basu, 2001. Liposomal antioxidants in combating ischemia-reperfusion injury in rat brain. Biomed. Pharmacol. Ther., 55: 264-271. DOI: 10.1016/S0753-3322(01)00060-96
32. Stuchbury, G. and G. Munch, 2005. Alzheimer's associated inflammation, potential drug targets and future therapies. J. Neural Transm., 112: 429-453. PMID: 157231596
33. Wang, X., H. He, W. Leng and X. Tang, 2006. Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method. Int. J. Pharm., 317: 40-46. DOI: 10.1016/j.ijpharm.2006.02.0556
34. Weinstock, M. and S. Shoham, 2004. Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity. J. Neural Transm., 111: 347-366. PMID: 149914596
35. Wu, H., K. Hu and X. Jiang, 2008. From nose to brain: Understanding transport capacity and transport rate of drugs. Expert Op. Drug Deliv., 5: 1159-1168. PMID: 188175196
36. Youdim, K.A., M.Z. Qaiser, D.J. Begley, C.A. Rice-Evans and N.J. Abbott, 2004. Flavonoid permeability across an in situ model of the bloodbrain barrier. Free. Radic. Biol. Med., 36: 592-604 PMID: 149807036
37. Zu, Y., C. Li, Y. Fu and C. Zhao, 2006. Simultaneous determination of catechin, rutin, quercetin kaempferol and isorhamnetin in the extract of sea buckthorn (Hippophae rhamnoides L.) leaves by RP-HPLC with DAD. J. Pharm. Biomed. Anal., 41: 714-719. PMID: 16520013